[KTTA] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
30-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 141.28%
YoY- 1,412.50%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 219 14 14 15 0 0 0 -
PBT -4,191 -2,658 -1,574 630 -1,526 -728 -550 286.75%
Tax 730 -843 -1,616 0 0 0 0 -
NP -4,586 -1,815 41 630 -1,526 -728 -550 310.66%
Tax Rate - - - -0.00% - - - -
Total Cost 4,805 1,829 -28 -615 1,526 728 550 323.62%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -2,097.88 -13,364.21 302.78 4,183.53 0.00 0.00 0.00 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -3.45 -0.08 0.00 0.06 -0.17 -0.07 -0.04 1846.83%
EPS Diluted -3.45 -0.08 0.00 0.06 -0.17 -0.07 -0.04 1846.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.